What FARMA+ does

FARMA+ UNIPESSOAL LDA is a Portuguese healthcare distribution company founded in 2013 and acquired in 2021 by Spain's Grupo PRIM, a Madrid Stock Exchange-listed healthcare conglomerate founded in 1870. The company operates exclusively through the Portuguese Pharmacy Channel (Canal Farmácia), positioning itself as a category-development partner that helps pharmacies become consumers' primary reference point for Mobility & Well-Being products. Its specialized national commercial team, composed of graduates in Pharmacy, Pharmaceutical Sciences, Orthoprothesis, Economics, Marketing, Management, and Physiotherapy, delivers in-person pharmacy engagement including staff training, creation of dedicated physical category spaces, optimized unit-per-reference stock rotation, and a Technical Support Hotline.

The product portfolio spans orthopedic and rehabilitation equipment under the PRIM brand, JUZO compression therapy, PrimSpine spinal orthoses, MYPRIM KIDS pediatric orthoses (launched May 2025), FISIOPRIM massage creams with Far Infrared technology, Mottio Sport and Aqtivo Sport performance supports, Comforsil podology products, Vitaflor royal-jelly supplements, Speed-Age frailty-prevention products, Cold2Sport cryotherapy, and Eye Care items. Technology-based services include the PIM (Preparação Individualizada da Medicação / Individualized Medication Preparation) platform with the Pil-Bob blister-extraction aid, customized pharmacy e-commerce storefronts, and patient-loyalty solutions, supported by the PRIM Academy e-learning platform and an extensive health-education blog.

The business model is one-time product sales through the pharmacy channel, supplemented by direct-to-consumer e-commerce via cuidamais.pt and farmamais.pt, with marketing conducted through a content-driven blog, YouTube, LinkedIn, Instagram, and Facebook channels, plus catalog distribution via the Closum platform. FARMA+ is privately held, operates only in Portugal, and has no independent outside investment or PE/VC backing identified in the available data; it functions as a strategic operating subsidiary of Grupo PRIM. Revenue is not publicly disclosed.

Name

FARMA+

Legal name

FARMA+ UNIPESSOAL LDA

Website

https://farmamais.pt

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

FARMA+ UNIPESSOAL LDA is a Portugal-based pharmacy-channel distribution subsidiary of Spain's Grupo PRIM, distributing orthopedic, compression-therapy, mobility, podology, and supplement products through a national commercial team while providing category management, training, and individualized medication preparation (PIM) services to Portuguese pharmacies.

Ownership category

akta.pro rank

Product category

Pharmaceutical and Orthopedic Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (4242), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)

akta.pro secondary industries

Medical Supplies & Consumables Wholesale (Non-Device) (CRAOAHAE), Pharmacy Supply Chain & Secondary Distribution (Repackagers/Redistributors) (CRAOAHAC), Vitamins & Minerals (Single Nutrients) (CRADAGAB)

Keywords

• Orthopedic product distribution
• Pharmacy channel distribution
• Mobility and compression therapy
• Podiatry and physiotherapy supplies
• Dietary supplement distribution

Headquarters

HQ city

Louro

HQ country

Portugal

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Supply Chain, Operations, Technology or R&D

Revenue model

1. Pharmacy Channel Product Sales: Sale of orthopedic products, compression therapy products (Juzo), mobility aids, technical assistance products, podology products, supplements, and personal care products through the pharmacy channel in Portugal.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

FARMA+ distributes orthopedic devices, mobility aids, compression therapy products, podiatry, physiotherapy creams, dietary supplements, and lip care products to Portuguese pharmacies under the Prim, Juzo, Comforsil, Vitaflor, and proprietary sub-brands. It pairs the product portfolio with value-added pharmacy services including category management, in-store merchandising, commercial training, technical support, the PIM individualized medication preparation service, and pharmacy e-commerce/loyalty programs.

Product overview

FARMA+ operates as a pharmaceutical/healthcare distribution company in Portugal, acquired by Grupo PRIM in 2021. The company offers a comprehensive portfolio of orthopaedic, mobility, and wellness products primarily through the pharmacy channel. The product ecosystem includes: core PRIM brand orthopaedic products; JUZO compression therapy products; PIM (Individualized Medication Preparation) service with tools like Pil-Bob; PrimSpine spinal orthoses including the new GOLD line; MYPRIM KIDS pediatric orthoses; FISIOPRIM massage creams with FIR technology; Comforsil podology products; Vitaflor royal jelly supplements; Aqtivo Sport and Mottio Sport athletic supports; Speed-Age frailty prevention products; Walker boots as cast alternatives; and Cold2Sport cryotherapy products. The company focuses on Mobility & Wellness category development in pharmacies, combining physical products with technological platforms for patient management and e-commerce solutions.

Differentiator

Problem solved

Functional benefit

Brands

• PRIM: Core brand of Grupo PRIM for hospital and orthopedic products, physiotherapy, technical aids, and rehabilitation solutions. Operated under the Portuguese pharmacy channel.
• JUZO
• PIM
• FISIOPRIM
• COMFORSIL
• MYPRIM KIDS
• PRIMSPINE
• Speed-Age
• Aqtivo Sport
• Mottio Sport
• Neoprair
• Cold2Sport
• SHABAY
• Vitaflor
• SPINAIR
• Pil-Bob
• VitalPrim
• Comforsil
• JWett
• Eye Care

Products and services

• PrimSpine orthopedic range (spinal orthoses) Spinal orthoses range under the Prim brand distributed to Portuguese pharmacies for patients requiring spinal support and posture correction.
• PrimSpine GOLD line Premium tier of PrimSpine spinal orthoses offering enhanced design and materials for spinal support indications, sold through Portuguese pharmacies.
• MYPRIM KIDS pediatric orthoses Pediatric line of orthoses under the MYPRIM KIDS brand designed to address orthopedic needs of children, distributed to Portuguese pharmacies.
• JUZO compression therapy products Juzo compression stockings and therapy garments distributed by FARMA+ in Portuguese pharmacies for venous and lymphatic conditions, with Oeko-Tex certification.
• Juzo Move Compression Stockings Active-wear style compression stockings from Juzo, distributed by FARMA+ to Portuguese pharmacies for consumers seeking everyday compression therapy.
• Comforsil podiatry products Comforsil brand podiatry and foot-care products, including orthotic insoles and foot supports, distributed by FARMA+ through Portuguese pharmacies.
• FISIOPRIM massage creams FISIOPRIM physiotherapy and massage creams distributed by FARMA+ through Portuguese pharmacies for therapeutic and sports recovery use.
• Vitaflor dietary supplements Vitaflor brand dietary supplements distributed by FARMA+ to Portuguese pharmacies for consumer wellness and nutritional support.
• Aqtivo Sport elastic supports Aqtivo Sport elastic supports designed for athletes, providing joint stabilization and injury prevention, distributed to Portuguese pharmacies.
• Mottio Sport high-performance supports Mottio Sport high-performance supports for athletes and active consumers, distributed by FARMA+ through Portuguese pharmacies.
• Walker Boot tibiotalar immobilizer Walker Boot walking immobilizer for tibiotalar (ankle) injuries and post-operative immobilization, distributed by FARMA+ to Portuguese pharmacies.
• Lip Care product line Lip care product line distributed by FARMA+ through Portuguese pharmacies for lip hydration, protection, and repair.
• Neoprair neoprene orthoses Neoprair neoprene orthoses for joint support and compression, distributed by FARMA+ through Portuguese pharmacies.
• Cold2Sport cryotherapy product Cold2Sport cryotherapy product for sports injury and post-exercise recovery, distributed by FARMA+ through Portuguese pharmacies.
• Speed-Age frailty prevention program Speed-Age program of products and services for frailty prevention in older adults, distributed by FARMA+ through Portuguese pharmacies.
• PIM (Personalized Individualized Medication) service PIM service supporting Portuguese pharmacies in individualized compounded medication preparation, including formulation support, technical guidance, and tooling for personalized therapies.
• Pharmacy e-commerce and loyalty platform service Dedicated pharmacy e-commerce platforms (cuidamais.pt, mobiwork.pt) and CRM/loyalty programs offered by FARMA+ to partner pharmacies to support online sales and consumer engagement.

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• PRIM (Parent Company)coreOthersGrupo PRIM acquired FARMA+ in 2021, operating it essentially in the Pharmacy Channel in Portugal. PRIM is a Spanish healthcare company founded in 1870, listed on Madrid Stock Exchange since 1985, recognized for hospital and orthopedic products, physiotherapy, thalassotherapy, thermalism, rehabilitation, geriatrics, and technical aids. The company has registered patents since 1880.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Sigvaris Group: Compression therapy brand competing directly with Juzo; comparable as a product-line competitor that FARMA+'s pharmacy merchandising must position against.
• medi GmbH & Co. KG: Compression therapy and orthopedic supports manufacturer (Juzo's main peer); comparable as a competitor whose products sit alongside Juzo on the same pharmacy shelves FARMA+ manages.

Broad incumbents

• Ottobock: Global orthopedic devices and mobility aids supplier; comparable as an upstream brand competing for the same Mobility & Well-Being shelf space that FARMA+ builds out in Portuguese pharmacies.
• Cofares: Spain-headquartered pharmacy cooperative and drug wholesaler with Portuguese presence; comparable as a large-scale distributor supplying retail pharmacies across Iberia with non-durable health goods.
• B. Braun: Medical and hospital supplies wholesaler/manufacturer with orthopedic and consumables portfolio; comparable as a larger player in medical-supply wholesale with overlapping product categories.
• Essity (BSN medical): Healthcare products group including BSN medical (orthopedics, compression, wound care); comparable as a broad incumbent whose medical division competes with FARMA+'s orthopedic and compression portfolio.

Direct peers

• Alliance Healthcare: Pharmaceutical wholesaler serving Portuguese pharmacies; comparable as a B2B distributor to the same SMB pharmacy channel that FARMA+ targets, with overlapping customer base and channel role.

Others

• Heraeus Medical: Medical products manufacturer with pharmacy-relevant portfolios; comparable as an adjacent medical-product supplier selling into similar healthcare distribution channels in Europe.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/PRIM.Portugal.PT
• LinkedInlinkedin.com/company/prim-pt
• Instagraminstagram.com/primportugal
• Xx.com/farmamais

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FARMA+